About BioSyent

Listed on the TSX Venture Exchange (TSXV: RX), BioSyent is a profitable growth oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical products that have been successfully developed, are proven safe and effective, and have track records of improving the lives of patients. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, specialty, and international business units.

What is our Business Philosophy?

At BioSyent, our business philosophy is firmly grounded in our commitment to serving patients and healthcare professionals. We understand the impact our work can have on individuals and their well-being, and so we approach it with compassion and a sense of responsibility. Through a data-driven approach, we uncover insights that shape our strategies, ensuring that our products and services meet the needs of those who depend on them. But we believe that true success lies in the effective implementation of our plans.

Leadership

René C. Goehrum

President & Chief Executive Officer

Robert J. March

Vice President & Chief Financial Officer

Marnie McCormick

Vice President & General Manager

Joost van der Mark

Vice President, Corporate Development

Kevin Wilson

Vice President, Sales

Navid Ashrafi, M.D.

Director, Medical and Regulatory Affairs

Neelu Atwal

Director, Human Resources

Ramesh Moothan

Director, International Business Unit

Sharan Raghubir

Director, Specialty Sales

Leadership full information

Board of Directors

Larry Andrews

Independent Director (Compensation and Human Resources Committee, Nominating Committee)

Joseph Arcuri

Independent Director (Audit Committee - Chair, Disclosure Policy Committee - Chair)

Sara Elford

Independent Director (Audit Committee, Disclosure Policy Committee, Nominating Committee - Chair)

René C. Goehrum

Chairman of the Board of Directors

Peter Lockhard

Independent Director (Lead Director, Compensation and Human Resources Committee)

Stephen Wilton

Independent Director (Audit Committee, Disclosure Policy Committee)

Board of Directors full information